About AIMA
AIMA is a company based in Vancouver (Canada) founded in 2019 by Lanna Last, Mali Meibod, and Melanie Ter Borg. AIMA has raised $600.7 thousand across 1 funding round from investors including IndieBio. The company has 5 employees as of December 31, 2024. AIMA offers products and services including OVY RELIEF™ and CBD / CBG Vaginal Suppositories. AIMA operates in a competitive market with competitors including Gynica and DELICS, among others.
- Headquarter Vancouver, Canada
- Employees 5 as on 31 Dec, 2024
- Founders Lanna Last, Mali Meibod, Melanie Ter Borg
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Aima Usa Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$600.7 K (USD)
in 1 rounds
-
Latest Funding Round
$600.7 K (USD), Seed
Dec 22, 2022
- Investors
-
Employee Count
5
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of AIMA
AIMA offers a comprehensive portfolio of products and services, including OVY RELIEF™ and CBD / CBG Vaginal Suppositories.
CBD and CBG suppository for relieving menstrual pain and symptoms.
Suppositories designed to manage pelvic pain during menstruation.
Funding Insights of AIMA
AIMA has successfully raised a total of $600.7K through 1 strategic funding round. The most recent funding activity was a Seed round of $600.7 thousand completed in December 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in AIMA
AIMA has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include IndieBio.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Biotech startups are accelerated through IndieBio's focused programs.
|
Locked | Locked | Locked |
Investor details for AIMA
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by AIMA
Investment portfolio details for AIMA
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - AIMA
Detailed financials for AIMA
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aima Comparisons
Peer comparison for AIMA
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of AIMA
AIMA operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Gynica and DELICS, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provides cannabinoid-based therapeutic solutions for women's health.
|
|
| Locked | Locked | Locked |
Provides cannabis-based oils designed to alleviate menstrual cramps.
|
Detailed competitors of AIMA
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aima
Complete news archive for AIMA
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AIMA
AIMA was founded in 2019 and raised its 1st funding round 3 years after it was founded.
AIMA is headquartered in Vancouver, Canada. It is registered at Vancouver, British Columbia, Canada.
Lanna Last is the current CEO of AIMA. They have also founded this company.
AIMA is a funded company, having raised a total of $600.7K across 1 funding round to date.
As of Dec 31, 2024, the latest employee count at AIMA is 5.
AIMA was founded in 2019 in Vancouver, Canada, as a provider of cannabis-infused products targeted at menstrual pain management. Operations are conducted in the health and wellness sector, where specialized formulations are developed and distributed to address period-related discomfort. The company is led by co-founders Lanna Last as CEO, Mali Meibod, and Melanie Ter Borg, with activities centered on product innovation and regulatory compliance in the Canadian market.
AIMA offers OVY RELIEF™ and CBD / CBG Vaginal Suppositories.
AIMA has 1 investor. Key investors include IndieBio.